Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 293

Results For "CRE"

4434 News Found

Kiran Mazumdar-Shaw awarded H. K. Firodia Lifetime Achievement Award 2022
People | September 26, 2022

Kiran Mazumdar-Shaw awarded H. K. Firodia Lifetime Achievement Award 2022

The committee unanimously decided to confer the Lifetime Achievement Award to Kiran Mazumdar-Shaw for her monumental contributions as a global leader in biotechnology innovation and entrepreneurship


AIIMS New Delhi celebrates 67th Foundation Day
News | September 26, 2022

AIIMS New Delhi celebrates 67th Foundation Day

India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery


JB Pharma rolls out its campaign #Heart2HeartChallengeIndia
Healthcare | September 24, 2022

JB Pharma rolls out its campaign #Heart2HeartChallengeIndia

The #Heart2HeartChallengeIndia campaign is very simple – you have to climb 60 steps in a minute, make a video of it, share it on your social media, tag 5 people, inviting them to take this challenge to check their heart health


Snazzy launches scan box and remote monitoring app to achieve 100% orthodontic goals
Startup | September 24, 2022

Snazzy launches scan box and remote monitoring app to achieve 100% orthodontic goals

The startup plans to provide free technology to dental clinics upon registration.


Madhavbaug plans to foray in UAE, Europe & US
Healthcare | September 24, 2022

Madhavbaug plans to foray in UAE, Europe & US

To set up 50 lifestyle modification centres across the UAE in the next 24 months


KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India
Healthcare | September 23, 2022

KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India

Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune


JB Pharma witness 20% growth in August 2022: IQVIA
News | September 22, 2022

JB Pharma witness 20% growth in August 2022: IQVIA

Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.


BridgeBio Pharma, Sentynl Therapeutics receive marketing authorization in the EU for fosdenopterin
Drug Approval | September 22, 2022

BridgeBio Pharma, Sentynl Therapeutics receive marketing authorization in the EU for fosdenopterin

NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.


Reasons for the surge in M& A in healthcare and pharmaceutical sectors in India: Ankit Poddar & Navroz Mahudawala, Candle Partners
Opinion | September 22, 2022

Reasons for the surge in M& A in healthcare and pharmaceutical sectors in India: Ankit Poddar & Navroz Mahudawala, Candle Partners

Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.


Azelis expands pharmaceutical offerings with Clariant
News | September 21, 2022

Azelis expands pharmaceutical offerings with Clariant

Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.